Background: Uveal melanoma (UM) is a rare subtype of melanoma that generally has a poor
prognosis once it has metastasized. Clinical trials evaluating immune checkpoint inhibitors …

Background: Uveal melanoma is the most common primary intraocular malignancy among
adults. It is, nevertheless, a rare disease, with an incidence of approximately one case per …

Introduction Uveal melanoma (UM) is the most common intraocular cancer and represents a
discrete subtype of melanoma. Metastatic disease, which occurs in half of patients, has a …

No standard treatment has been established for metastatic uveal melanoma (mUM).
Immunotherapy is commonly used for this disease even though UM has not been included …

Uveal melanoma (UM) is a rare cancer with a high mortality rate. In comparison to
cutaneous melanoma, UM has unique immunological features. Arising in the immune …

Background: Uveal melanoma is a rare subtype of melanoma. Prognosis and survival rates
for patients with metastatic uveal melanoma remain poor. No current FDA-approved …

Uveal melanoma (UM) is one of the rare malignancies, which can be lethal despite local
treatment. Treatment options available now can control UM in early stages, but once it …

Abstract Purpose of Review Uveal melanoma is a distinct subset of melanoma with a biology
and treatment approach that is unique from that of cutaneous melanoma. Here we will …

Uveal melanoma is the most prevalent primary intraocular tumour in adults with the
incidence between five and six cases per million people in the United States and Europe …

Uveal melanoma is the most common primary intraocular tumor in adults. 1 Before the mid-
20th century, enucleation was the mainstay of treatment for uveal melanoma. Although this …